S. Cnattingius et al., PRENATAL AND NEONATAL RISK-FACTORS FOR CHILDHOOD MYELOID-LEUKEMIA, Cancer epidemiology, biomarkers & prevention, 4(5), 1995, pp. 441-445
Information about the etiology of childhood myeloid leukemia is limite
d, A population-based nested case-control study of prenatal and neonat
al risk factors for childhood myeloid leukemia was performed with the
use of the Swedish National Cancer Register and the Swedish Birth Regi
ster, A total of 98 cases of myeloid leukemia were identified in succe
ssive birth cohorts from 1973 through 1989, From the Birth Register, f
ive controls were matched to each case. Fourteen of the 98 cases with
myeloid leukemia and none of the controls had Down syndrome [odds rati
o (OR) = infinity; 95% confidence interval (CI) = 21.0-infinity]. The
risk for myeloid leukemia also increased among children who had physio
logical jaundice (OR = 2.5; 95% CI = 1.2-5.0); children who had been t
reated with phototherapy (OR = 7.5; 95% CI = 1.8-31.9); or who had bee
n treated in an incubator (OR = 3.5; 95% CI = 1.2-10.2). Excluding cas
es with Down syndrome, however, decreased these risks, so that their 9
5% lower confidence interval included the no-effect value, Maternal ag
e <20 years old (OR = 2.5; 95% CI = 1.1-6.0), hypertension (OR = 2.4;
95% CI = 1.2-5.0), Cesarean section (OR = 2.5; 95% CI = 1.3-4.9), mate
rnal smoking (OR = 2.4; 95% CI = 0.9-6.5), and being one of a multiple
birth (OR = 3.6; 95% CI = 1.1-11.3) increased the risk for myeloid le
ukemia among those without Down syndrome, When the analyses were repea
ted, by restricting the cases to those with acute myeloid leukemia, th
e risk associated with young maternal age declined and became nonsigni
ficant. Down syndrome is markedly associated with increased risk of my
eloid leukemia, Because Down syndrome is underreported in the Birth Re
gister. Down syndrome may give rise to some residual confounding, ther
eby accounting for some of the other associations obtained, Besides Do
wn syndrome, the other medical condition or factors linked with increa
sed risk of myeloid leukemia, need additional confirmation.